CIK 0001867096
- Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 871082097
- Phone
- +1 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | McCulloch Kevin | Sale 10b5-1 | −25,000 | $12.49 | $312K | 1,559,208 |
| 2026-11-02 | McCulloch Kevin | Sale 10b5-1 | −15,000 | $10.23 | $153K | 1,584,208 |
| 2026-10-01 | McCulloch Kevin | Sale 10b5-1 | −15,000 | $9.41 | $141K | 1,599,208 |
| 2026-09-28 | McCulloch Kevin | Sale 10b5-1 | −25,000 | $10.00 | $250K | 1,614,208 |
| 2026-09-01 | McCulloch Kevin | Sale 10b5-1 | −15,000 | $8.49 | $127K | 1,639,208 |
| 2026-08-03 | McCulloch Kevin | Sale 10b5-1 | −15,000 | $8.02 | $120K | 1,676,126 |
| 2026-08-01 | McCulloch Kevin | Shares withheld for taxes | −21,918 | $8.08 | $177K | 1,654,208 |
| 2026-07-01 | McCulloch Kevin | Sale 10b5-1 | −90,000 | $8.03 | $723K | 1,691,126 |
| 2026-03-12 | McCulloch Kevin | Exercise or conversion | +48,894 | $4.09 | $200K | 1,777,721 |
| 2026-03-12 | McCulloch Kevin | Exercise or conversion | +4 | $3.94 | $16 | 1,777,725 |
| 2026-03-12 | McCulloch Kevin | Exercise or conversion · Stock Option (Right to Buy) | −48,894 | $4.09 | $200K | 43,773 |
| 2026-03-12 | McCulloch Kevin | Exercise or conversion · Stock Option (Right to Buy) | −4 | $3.94 | $16 | 79,996 |
| 2026-01-31 | McCulloch Kevin | Shares withheld for taxes | −68,454 | $7.36 | $504K | 1,785,435 |
| 2026-01-31 | McCulloch Kevin | Shares withheld for taxes | −30,289 | $7.36 | $223K | 1,755,146 |
| 2026-01-31 | McCulloch Kevin | Shares withheld for taxes | −27,319 | $7.36 | $201K | 1,727,827 |
| 2026-01-30 | McCulloch Kevin | Grant or award | +168,463 | 1,853,889 | ||
| 2026-01-30 | McCulloch Kevin | Grant or award · Stock Option (Right to Buy) | +225,225 | 225,225 | ||
| 2026-01-08 | McCulloch Kevin | Sale 10b5-1 | −15,000 | $8.00 | $120K | 1,685,426 |
| 2025-10-02 | McCulloch Kevin | Shares withheld for taxes | −733 | $8.31 | $6K | 1,700,426 |
| 2025-09-11 | McCulloch Kevin | Other disposition | −2,000 | 0 |
Page 1 of 2 · 30 trades